Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin

Verwaal, V J LU and Zoetmulder, F A N (2004) In European Journal of Surgical Oncology 30(3). p.280-285
Abstract

AIM: The aim of this study was to determine the value of medical history and physical examination, tumour marker testing, and CT-scanning in the follow-up of patients treated for peritoneal carcinomatosis of colorectal origin.

METHODS: Between November 1995 and June 2003, 107 patients were treated by cytoreduction and hyperthermic intra-peritoneal chemotherapy. The treatment was considered effective if residual tumour after cytoreduction was no thicker than 2.5 mm. The follow-up consisted of history, physical examination, serum CEA and CA 19.9 testing three-monthly, and CT-scanning of the abdomen six-monthly. Location of the recurrence was categorized into intra-abdominal, hepatic, thoracic, and both intra-abdominal and systemic.... (More)

AIM: The aim of this study was to determine the value of medical history and physical examination, tumour marker testing, and CT-scanning in the follow-up of patients treated for peritoneal carcinomatosis of colorectal origin.

METHODS: Between November 1995 and June 2003, 107 patients were treated by cytoreduction and hyperthermic intra-peritoneal chemotherapy. The treatment was considered effective if residual tumour after cytoreduction was no thicker than 2.5 mm. The follow-up consisted of history, physical examination, serum CEA and CA 19.9 testing three-monthly, and CT-scanning of the abdomen six-monthly. Location of the recurrence was categorized into intra-abdominal, hepatic, thoracic, and both intra-abdominal and systemic. The investigation that led to the detection of a recurrence was ranked according to its invasiveness and costs. The simplest investigation that could have led to the detection was marked.

RESULTS: A recurrence developed in 63 patients of the 74 patients effective initial treatment during the study period. Physical examination revealed the recurrence in 38 patients, at least one of the markers was raised above normal value in 39 patients and in 37 patients the CT-scan showed the recurrence. History and physical examination could have triggered the finding of a recurrence in 38 patients, tumour markers in 21 patients and CT-scanning in only three of the 74 recurrences.

CONCLUSION: Physical examination and tumour marker testing detect most recurrences. CT-scanning is not an effective tool in the follow-up, and should be reserved for on-demand use.

(Less)
Please use this url to cite or link to this publication:
author
and
publishing date
type
Contribution to journal
publication status
published
keywords
Adult, Aged, Antineoplastic Agents/administration & dosage, Appendiceal Neoplasms/blood, Biomarkers, Tumor/blood, CA-19-9 Antigen/blood, Carcinoembryonic Antigen/blood, Colorectal Neoplasms/blood, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Hyperthermia, Induced/methods, Infusions, Parenteral, Male, Medical History Taking, Middle Aged, Neoplasm Recurrence, Local/blood, Peritoneal Neoplasms/blood, Physical Examination, Surgical Procedures, Operative/methods, Tomography, X-Ray Computed
in
European Journal of Surgical Oncology
volume
30
issue
3
pages
280 - 285
publisher
Elsevier
external identifiers
  • scopus:1842592089
  • pmid:15028309
ISSN
0748-7983
DOI
10.1016/j.ejso.2003.12.003
language
English
LU publication?
no
id
391b966f-23d4-4b00-a014-eb9410b8c2ff
date added to LUP
2022-04-12 10:50:19
date last changed
2024-01-08 03:40:22
@article{391b966f-23d4-4b00-a014-eb9410b8c2ff,
  abstract     = {{<p>AIM: The aim of this study was to determine the value of medical history and physical examination, tumour marker testing, and CT-scanning in the follow-up of patients treated for peritoneal carcinomatosis of colorectal origin.</p><p>METHODS: Between November 1995 and June 2003, 107 patients were treated by cytoreduction and hyperthermic intra-peritoneal chemotherapy. The treatment was considered effective if residual tumour after cytoreduction was no thicker than 2.5 mm. The follow-up consisted of history, physical examination, serum CEA and CA 19.9 testing three-monthly, and CT-scanning of the abdomen six-monthly. Location of the recurrence was categorized into intra-abdominal, hepatic, thoracic, and both intra-abdominal and systemic. The investigation that led to the detection of a recurrence was ranked according to its invasiveness and costs. The simplest investigation that could have led to the detection was marked.</p><p>RESULTS: A recurrence developed in 63 patients of the 74 patients effective initial treatment during the study period. Physical examination revealed the recurrence in 38 patients, at least one of the markers was raised above normal value in 39 patients and in 37 patients the CT-scan showed the recurrence. History and physical examination could have triggered the finding of a recurrence in 38 patients, tumour markers in 21 patients and CT-scanning in only three of the 74 recurrences.</p><p>CONCLUSION: Physical examination and tumour marker testing detect most recurrences. CT-scanning is not an effective tool in the follow-up, and should be reserved for on-demand use.</p>}},
  author       = {{Verwaal, V J and Zoetmulder, F A N}},
  issn         = {{0748-7983}},
  keywords     = {{Adult; Aged; Antineoplastic Agents/administration & dosage; Appendiceal Neoplasms/blood; Biomarkers, Tumor/blood; CA-19-9 Antigen/blood; Carcinoembryonic Antigen/blood; Colorectal Neoplasms/blood; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperthermia, Induced/methods; Infusions, Parenteral; Male; Medical History Taking; Middle Aged; Neoplasm Recurrence, Local/blood; Peritoneal Neoplasms/blood; Physical Examination; Surgical Procedures, Operative/methods; Tomography, X-Ray Computed}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{280--285}},
  publisher    = {{Elsevier}},
  series       = {{European Journal of Surgical Oncology}},
  title        = {{Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin}},
  url          = {{http://dx.doi.org/10.1016/j.ejso.2003.12.003}},
  doi          = {{10.1016/j.ejso.2003.12.003}},
  volume       = {{30}},
  year         = {{2004}},
}